SEMA3G (Center) Rabbit Polyclonal Antibody
CAT#: AP53845PU-N
SEMA3G (Center) rabbit polyclonal antibody, Aff - Purified
Need it in bulk or conjugated?
Get a free quote
CNY 6,160.00
货期*
5周
规格
Cited in 5 publications. |
Specifications
Product Data | |
Applications | IHC, WB |
Recommend Dilution | ELISA: 1/1,000. Western blotting: 1/1000. Immunohistochemistry: 1/50-1/100. |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | KLH conjugated synthetic peptide between 216-244 amino acids from the Central region of Human SEMA3G |
Specificity | Recognizes SEMA3G (Center). |
Formulation | PBS with 0.09% (W/V) Sodium Azide as preservative State: Aff - Purified State: Liquid purified Ig fraction |
Concentration | lot specific |
Purification | Protein A column followed by peptide Affinity purification |
Conjugation | Unconjugated |
Storage Condition | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. |
Gene Name | semaphorin 3G |
Database Link | |
Background | SEMA3G has chemorepulsive activities for sympathetic axons. Ligand of NRP2 (By similarity). |
Synonyms | Semaphorin-3G, Semaphorin sem2 |
Note | Molecular Weight: 86701 Da |
Reference Data | |
Protein Families | Druggable Genome, Secreted Protein |
Protein Pathways | Axon guidance |
Citations (5)
The use of this Antibodies has been cited in the following citations: |
---|
Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
,Karayan-Tapon L, Wager M, Guilhot J, Levillain P, Marquant C, Clarhaut J, Potiron V, Roche J,
Br. J. Cancer
,PubMed ID 18781179
[SEMA3G]
|
Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells
,Kigel B, Varshavsky A, Kessler O, Neufeld G,
PLoS ONE
,PubMed ID 18818766
[SEMA3G]
|
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study
,Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators,
Diabetes Care
,PubMed ID 20628086
[SEMA3G]
|
Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip
,Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR, Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M, Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C, Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Munroe PB, Day IN, Kiv,
Am. J. Hum. Genet.
,PubMed ID 19913121
[SEMA3G]
|
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
,Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li D, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, Comb MJ,
Cell
,PubMed ID 18083107
[SEMA3G]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...